Skip to content

Epidaurus · Treatment Guide · Wellness & Preventive Care

Going abroad for —

Longevity Medicine Quality

Anti-aging and longevity program quality

The country comparison

Which countries are best for longevity medicine quality

The destinations ranked high→low under this lens — each with the reasoning behind its score, the cited evidence one click down, and its full report. The verdict is free; the report is the depth.

19 / 19 Countries ranked

Researched and assessed by the Epidaurus editorial pipeline against our published scale. A country below the rule is not yet assessed enough — never ranked last.

  1. 1 United Arab Emirates AE 4.5/5 Good The UAE demonstrates world-class longevity medicine infrastructure with 10+ dedicated clinics, board-certified multidisciplinary teams, and world-first regulatory frameworks (HLMC licensing, DHA standards). Comprehens... Full report
    The evidence behind this score 9 cited points
    • 10+ dedicated longevity clinics across Dubai and Abu Dhabi (AEON, Pura, King's College Hospital Dubai, Bioscience Institute, DNA Health Corp with 6 locations, Biongevity, SKIN111, Eternell, Elite Vita, RENU, Vitruvian Medical, Dynasty Clinic, Clinique La Prairie)
    • World's first HLMC licensing framework issued by Abu Dhabi DoH (April 2025); AEON is sole Middle East affiliate of American Board of Regenerative Medicine
    • Biological age testing via OMICm Age, TruAGE, and telomere-based epigenetic clocks; comprehensive functional diagnostics including VO2 max, vascular age, gut microbiome, continuous glucose monitoring, cognitive assessment
    • NAD+ therapy (AED 590–1,000+), MSC stem cell therapy (AED 18,400–140,000), exosome therapy, peptide protocols, HBOT, ozone/EBOO, photobiomodulation; senolytic treatments explicitly absent
    • AI-enabled personalized protocols mandated by DoH HLMC standards; genomics-informed treatment sequencing; quarterly biomarker reassessment
    • 220+ JCI-accredited hospitals, 691,000 medical tourists in 2023, new streamlined medical visa framework (June 2026); international concierge at Atlantis and One&Only locations
    • Comprehensive 3–6 month programs AED 17,500–32,500 (USD 4,760–8,850); substantially below Switzerland (€15,000–50,000+), comparable to Germany
    • Limited published clinical outcomes; no peer-reviewed UAE-sourced trial data on biological age reversal; clinics report early DoH indicators and biomarker improvements but lack peer-reviewed evidence
    • $25.5 billion HELM cluster (NYU Abu Dhabi, Abu Dhabi Stem Cells Centre, UAE University) expected to catalyze local clinical longevity research in coming years

    Read the full United Arab Emirates report →

  2. 2 United Kingdom GB 4.5/5 Good The UK demonstrates world-class longevity medicine infrastructure with 65+ clinics offering comprehensive evidence-based treatments including NAD+ therapy, rapamycin, peptide therapies, and regenerative cell treatment... Full report
    The evidence behind this score 8 cited points
    • 65+ longevity clinics and hubs in UK with 20 dedicated clinics and 45 services concentrated in London (Harley Street Longevity Club, Harpal Clinic, London Regenerative Institute, My Longevity Centre)
    • Comprehensive treatment availability including NAD+ IV (£370-£2,800/session), rapamycin, metformin, peptide therapies (Epithalon, MOTS-c, Humanin), exosome therapy, and regenerative cell therapies
    • Multiple epigenetic biological age testing platforms readily available: TruAge COMPLETE (£380), GlycanAge (£285-289), with ISO 15189-accredited laboratories and 60+ biomarker panels at leading clinics
    • Practitioners include FAAMFM-certified physicians, MRCGP specialists with Anti-Ageing Medicine postgraduate certificates, and PhD-level cell biologists; all GMC-registered
    • UK Biobank (500,000+ participants) and Ageing Research at King's (ARK) provide world-leading research infrastructure; Oxford published research on rapamycin targeting senescent cells
    • Regulatory framework: GMC specialist registration, CQC facility oversight, and MHRA medicine approval; 2025-26 MHRA regulatory overhaul accelerates clinical trials
    • Costs range £1,500-£25,000/year; high by international standards with report noting London tech professionals seeking cheaper equivalent programmes in Bratislava
    • Published peer-reviewed clinical outcome data from specific UK longevity clinics remain limited; LRI's 6-year biological age reduction claim is clinic-reported rather than externally validated

    Read the full United Kingdom report →

  3. 3 Singapore SG 4.5/5 Good Singapore demonstrates world-class longevity medicine infrastructure with 10+ dedicated clinics, internationally recognized specialists (notably Prof. Andrea Maier), and comprehensive evidence-based treatments includi... Full report
    The evidence behind this score 8 cited points
    • 10+ dedicated private longevity clinics (Chi Longevity, Helixprive, NOVI Health, MORROW, Lifespan Asia, Artisan Regenerative Centre, NutraNourish) plus public Alexandra Hospital Healthy Longevity Research Clinic
    • Board-certified specialists including Prof. Andrea Maier (NUS Oon Chiew Seng Professor in Functional Ageing), Dr. Sumit Jain (AAAM member), and IFM-certified practitioners
    • Comprehensive treatments: NAD+ IV (100-250mg), senolytic-peptide sequencing (dasatinib + quercetin + BPC-157/GHK-Cu), 8 therapeutic peptides, HBOT (2.0+ ATA), GLP-1 agonists
    • Epigenetic age testing from multiple providers using DunedinPACE, GrimAge, PhenoAge, Horvath algorithms; comprehensive biomarker panels (80-100+ markers)
    • Published clinical evidence: randomized double-blind NMN trial (2024), PROMETHEUS trial XPRIZE semi-finalist (2025), 'Towards Precision Geromedicine in Singapore' (GeroScience 2025), new Clinical Trial Centre (October 2025)
    • Exceptional medical tourism: JCI-accredited hospitals, Four Seasons-integrated clinic, virtual programs, 646,000 international patients in 2024
    • SGD 350 million government commitment to Grand Challenge on Maximising Healthy and Successful Longevity (May 2026)
    • Limitations: advanced stem cell therapies unavailable (regulatory restriction), limited published private-sector outcomes, supplement quality concerns documented

    Read the full Singapore report →

  4. 4 Thailand TH 4.5/5 Good Thailand demonstrates world-class longevity medicine infrastructure with 60+ JCI-accredited centers and multiple specialized facilities offering comprehensive evidence-based treatments including NAD+ therapy, MSC cell... Full report
    The evidence behind this score 8 cited points
    • 60+ JCI-accredited medical centers with specialized regenerative medicine departments ensuring Western-standard safety protocols
    • Multiple established facilities with 20+ years track record: VitalLife Scientific Wellness Center, Regeneration Center (18 years), StemCells21 (12 years), award-winning Healthi-Life
    • Comprehensive treatments available: NAD+ IV therapy, umbilical cord-derived MSC cellular therapies (Thai FDA/Medical Council approved), peptide therapies (MOTS-c, BPC-157, Thymosin Alpha-1), exosome therapy
    • Multiple biological age testing options readily available: epigenetic clocks (Welala first in Asia-Pacific region), telomere length testing, DunedinPACE Epigenetic Clock at Bumrungrad
    • Personalized medicine approaches: VitalLife offers DNA sequencing and AI-driven platform with daily monitoring; StemCells21 tailors protocols based on patient condition and cell dosing
    • Qualified specialists with American Board of Anti-Aging Medicine diplomas and advanced international training
    • Exceptional medical tourism infrastructure: 3 million international patients annually, concierge services, airport support, English-fluent staff, short waiting times
    • Cost-competitive pricing: stem cell therapy 57% less than US average ($6,400-$8,900 vs $18,000); comprehensive programs $360-$4,500 USD; 50-70% savings versus US/Europe

    Read the full Thailand report →

  5. 5 Israel IL 4.5/5 Good Israel demonstrates world-class longevity medicine infrastructure with exceptional research credentials and specialist expertise, particularly through Sheba Medical Center's landmark 2023 public hospital clinic, the S... Full report
    The evidence behind this score 5 cited points
    • Sheba Medical Center Longevity Center (world's first public hospital longevity clinic, JCI-accredited, Newsweek top-10 ranked); Sagol Center for Hyperbaric Medicine with 300+ daily patient volume; Centa Longevity with 4,000 m² facility
    • 2020 Aging journal: telomere lengthening up to 38% and senescent cell reduction 37% from HBOT; 2024 BMC Geriatrics RCT on physical performance enhancement in aging adults
    • 450+ biomarker assessment panel with biological age evaluation, epigenetic clocks (IMECS reference data), telomere length testing, genetic profiling (APOE, longevity variants); personalized protocols and follow-up monitoring
    • International partnerships (Mayo Clinic Center on Aging, Singapore Centre for Healthy Longevity); 92% of Israeli physicians English-speaking; Sheba Global Patient Services; $2 billion invested in longevity biotech sector
    • Medical costs 30-50% below US; BUT: international pricing not publicly disclosed, HBOT/IV NAD+ infusion modalities less documented than in mature markets, dedicated programs opened late 2023 limiting long-term outcome evidence

    Read the full Israel report →

  6. 6 Japan JP 4.5/5 Good Japan operates one of Asia's most sophisticated longevity medicine ecosystems with 10+ world-class dedicated clinics, MHLW-regulated treatment protocols, and JAAM-certified board-certified specialists. The country off... Full report
    The evidence behind this score 7 cited points
    • At least 10 dedicated longevity medicine clinics in Tokyo (Ginza/Kyobashi) and Osaka, including Tokyo Relife Clinic, Cell Grand Clinic, The Hundred Longevity House, Tokyo Ginza Wellness & Aging Clinic, NEO Clinic Tokyo, Japan Longevity Clinic, and Artisan Clinic Hibiya
    • Full treatment spectrum available: adipose-derived stem cell therapy, exosome therapy, NMN/NAD+ IV infusions, senolytic protocols (dasatinib/quercetin), NK cell immunotherapy, epigenetic clock testing, and telomere length analysis
    • World-leading regulatory framework: 2014/2024 Act on the Safety of Regenerative Medicine with MHLW registration required; leading clinics hold 13-15+ government-approved treatment protocols; Japanese Society of Anti-Aging Medicine (JAAM) with 8,200+ board-certified members provides institutional accountability
    • Epigenetic clock testing and telomere analysis available at multiple clinics; personalized treatment protocols based on biomarker analysis (Tokyo Relife uses before/after epigenetic tracking; NEO Clinic personalizes senolytic protocols by patient labs)
    • Medical tourism infrastructure: JMIP accreditation, multilingual support (English, Chinese), remote pre-consultations, hotel concierge services; Japan Medical Tourism market estimated at USD 14.5 billion in 2025
    • Competitive international pricing: stem cell therapy 20-40% less expensive than Switzerland or Germany; NMN IV from ¥19,800 (~$130); comprehensive packages ~¥316,800 (~$2,100); stem cell therapy ¥1.5M-¥5M ($10,000-$33,000)
    • Limited published clinical outcomes from private clinics reflects global evidence gap; Japan pioneered first human NMN clinical trial (Keio University/Washington University, 2016); Lancet Healthy Longevity published epigenetic profiles of Japanese supercentenarians (2023)

    Read the full Japan report →

  7. 7 Mexico MX 4.0/5 Good Mexico has several established longevity medicine clinics with internationally-trained physicians offering a comprehensive range of evidence-based treatments including stem cell therapy, NAD+, peptides, and exosomes. ... Full report
    The evidence behind this score 7 cited points
    • Multiple dedicated longevity clinics across Mexico City, Los Cabos, Tijuana, Puerto Vallarta, Cancun, and Playa del Carmen with internationally-trained physicians (Harvard, NYU, American College of Surgeons)
    • Comprehensive treatment offerings including IV MSCs, localized stem cell injections, exosomes, NK-cell immunotherapy, NAD+ therapy, and advanced peptide therapies (GLP-1, GLP-2, GLP-3, BPC-157)
    • Leading facilities like LONVIDA practice personalized 'Medicine 3.0' with comprehensive biomarker analysis of 1,000+ biomarkers via AI, and Longevity Medical Institute offers genomic panels and in-house diagnostics
    • Mexico is the leading destination for medical travel by Americans with excellent infrastructure including boutique accommodations, concierge coordination, airport proximity, and English-speaking staff
    • Stem cell therapy costs range $2,500–$15,000 (50–70% cheaper than US), with all-inclusive longevity packages at $4,250
    • COFEPRIS regulatory framework and Mexican adoption of US hospital standards for JCI accreditation provide oversight, though specific regulations for therapeutic applications are incomplete as of 2019
    • Limited published clinical outcomes specific to Mexican longevity clinics in peer-reviewed databases; epigenetic clock testing and telomere length analysis not widely documented in clinic offerings

    Read the full Mexico report →

  8. 8 Malaysia MY 4.0/5 Good Malaysia demonstrates good-quality longevity medicine infrastructure with 10+ established clinics, multiple IFM-certified practitioners, and comprehensive evidence-based treatments including NAD+ IV, peptides, MSC the... Full report
    The evidence behind this score 7 cited points
    • 10+ dedicated longevity clinics in Malaysia, including Longevity Clinic by Medkos (first IFM-recognized longevity center in ASEAN), Emagene Life, FirstCell Malaysia, Merkel Clinic with IFM-certified physicians (Dr. Key Ng, Dr. Shirley Koeh, Dr. Irdina Aminuddin—Malaysia's first IFM scholarship recipient)
    • Comprehensive treatment availability: NAD+ IV therapy (RM 888–4,288/session), peptide therapies (RM 500–3,000/month), MSC stem cell longevity packages (USD $9,800–19,800), exosome therapy (RM 8,000–20,000), bioidentical hormone optimization as part of integrated protocols
    • Excellent biological age assessment infrastructure: epigenetic clock testing (TruAge COMPLETE, myDNAge, GlycanAge at RM 1,500–4,000), telomere length testing (RM 1,500–2,500), WellLab Malaysia dedicated anti-aging panel with NAD profile and mitochondrial function testing
    • Personalized protocols emphasized: Longevity Clinic by Medkos offers 9-step stem cell intervention with 5D LifeClock combining epigenetic testing, genomic screening, hormonal biomarkers; Emagene Life uses AI-augmented clinical decision support
    • 1.6 million international healthcare travelers in 2024 generating RM 2.72 billion in revenue; government declared 2026 Year of Medical Tourism with anti-aging as priority sector; PlacidWay, Bookimed, CureMeAbroad actively promote Malaysian clinics with multilingual support and transparent pricing
    • Regulatory concern: MSC stem cell therapies classified as investigational by MOH/NPRA yet commercially marketed by multiple clinics without public disclosure of CGTP registration or clinical trial enrollment; ZELL-V xenogenic cellular therapy lacks robust RCT evidence
    • No published large-cohort clinical outcomes from Malaysian longevity clinics as of research date; outcomes tracked via self-reported platform ratings and testimonials rather than peer-reviewed studies

    Read the full Malaysia report →

  9. 9 Germany DE 4.0/5 Good Germany demonstrates good longevity medicine infrastructure with several established clinics, 1,000+ GSAAM-certified specialists, comprehensive treatment options including cellular therapies and advanced diagnostics, ... Full report
    The evidence behind this score 7 cited points
    • 13+ verified longevity clinics including YEARS, Axmann & Gartenbach, ANOVA IRM, Lanserhof Tegernsee across Berlin, Munich, Frankfurt, and other cities
    • 1,000+ GSAAM-certified physicians providing specialty credentialing for anti-aging practitioners across Germany
    • Comprehensive treatment availability: NAD+ IV therapy, mesenchymal stem cell secretome, IHHT, HBOT, epigenetic clocks, telomere testing, multi-omics panels, senolytic protocols, pharmacogenomics, and liquid biopsy cancer screening
    • Exceptional diagnostic capabilities at YEARS: 87-200+ biomarkers depending on tier, whole-body MRI, microbiome profiling, pharmacogenomics, and epigenetic aging clocks with ongoing longitudinal clinical registry
    • World-class research infrastructure: Max Planck Institute for Biology of Ageing, CECAD Cluster of Excellence, Leopoldina policy framework calling for institutionalized geromedicine
    • Regulatory rigor: PEI GMP-certified requirements for stem cell preparations; ANOVA IRM is world's first clinic with governmental authorization for autologous secretome
    • Good medical tourism infrastructure: JCI accreditation, TEMOS certification, English-language support, 13+ clinics bookable via Bookimed, estimated costs €1,900-€35,000 for comprehensive programs

    Read the full Germany report →

  10. 10 Spain ES 4.0/5 Good Spain has established a substantial longevity medicine sector with 10+ dedicated clinics staffed by board-certified specialists (neurosurgeons, endocrinologists, anti-aging medicine experts), comprehensive evidence-ba... Full report
    The evidence behind this score 10 cited points
    • Life Length Madrid provides world-leading CLIA-certified and ISO 15189-accredited telomere analysis (HealthTAV®) distributed to 35+ countries, with co-founder Dr. María Blasco Marhuenda as leading telomere biologist
    • Approximately 10+ dedicated longevity medicine facilities across Madrid, Barcelona, Valencia, Alicante, Ibiza, Marbella, and Mallorca, staffed by board-certified specialists including neurosurgeons, endocrinologists, and functional medicine experts
    • Comprehensive diagnostic capabilities: Age Reversal's 1,000+ data point assessments (whole genome sequencing, whole-body MRI, multi-cancer liquid biopsy), epigenetic age testing, biochip technology detecting 70+ genetic polymorphisms, and telomere-based biological age analysis
    • Comprehensive treatment range including NAD+ IV therapy, hyperbaric oxygen, cryotherapy, cellular regeneration, senolytic protocols, peptide therapies, and intermittent hypoxia-hyperoxia training across multiple clinics
    • Strong medical tourism infrastructure with English-language services standard, multilingual support (English, German, Russian), telemedicine follow-up, concierge services, hotel partnerships, and 30-50% cost advantage over US programs (€1,250-€25,000 vs. $30,000+ USD)
    • Regulatory baseline established through Regional Health Ministry authorization requirements for IV therapy clinics and AEMPS/EMA oversight for stem cell therapies, with 21 JCI-accredited hospitals providing emergency medical safety net
    • International recognition through Madrid's selection to host Longevity World Forum 4th edition in 2026, attended by researchers from US National Institute on Aging and Albert Einstein College of Medicine
    • LIMITATION: No published peer-reviewed clinical outcome studies from Spanish longevity clinics on program effectiveness, limiting evidence of real-world results
    • LIMITATION: Spain lacks unified regulatory definition of 'longevity clinic' as a healthcare category, creating variable governance standards across facilities
    • LIMITATION: Several clinics (BL Longevity, others) mix cosmetic procedures (liposuction, facial rejuvenation) with longevity medicine, diluting evidence-based medical focus

    Read the full Spain report →

  11. 11 United States US 3.5/5 Moderate The U.S. has a world-leading longevity medicine infrastructure with approximately 800 clinics, academic medical center involvement (Mayo Clinic), comprehensive evidence-based treatments (NAD+ therapy, stem cells, seno... Full report
    The evidence behind this score 5 cited points
    • Approximately 800 longevity clinics operate in the United States, including academic centers like Mayo Clinic and private facilities like Fountain Life with 4 flagship locations
    • FDA does not recognize aging as a disease indication and has no regulatory pathway for anti-aging interventions, creating a regulatory vacuum for many treatments
    • Comprehensive treatments available including NAD+ therapy (pioneered 2001), stem cell and PRP therapies, senolytic treatments in clinical trials, and FDA-registered EPIAGE epigenetic clock testing
    • Strong clinical research infrastructure with 16 registered dasatinib/quercetin trials on clinicaltrials.gov and published outcomes data demonstrating senescent cell reduction
    • Costs range from $10,000 to over $150,000 annually, the highest globally, and most services lack insurance coverage, limiting value proposition compared to international alternatives

    Read the full United States report →

  12. 12 Brazil BR 3.5/5 Moderate Brazil has developed a moderately active longevity medicine sector with several established clinics, over 17,000 trained physicians, and access to advanced treatments including stem cell therapies and epigenetic age t... Full report
    The evidence behind this score 4 cited points
    • Several specialist longevity clinics operate (Instituto Assaly, Enjoy Institute, Clínica de Longevidade, Instituto Garaude), but no Brazilian facility appears in World Longevity Clinics' global directory of 55 clinics
    • Biological age testing (TruAge epigenetic clock, BioAge telomere test) commercially available; stem cell therapies offered at $3,000–$10,000 USD (50–70% below US prices)
    • 17,000+ physicians trained by Grupo Longevidade Saudável; Sociedade Brasileira de Medicina da Longevidade (SBML) formally inaugurated 2024; ANVISA approved NMN as supplement ingredient (2025)
    • Published clinical outcomes from Brazilian longevity programs are limited; most peptide therapies operate without ANVISA registration; CFM has prohibited anti-aging use of hormones/supplements since 2012

    Read the full Brazil report →

  13. 13 Colombia CO 3.5/5 Moderate Colombia has established multiple dedicated longevity clinics with qualified practitioners, offering a comprehensive range of evidence-based treatments (stem cell therapy, NAD+ IV, peptide therapies, biomarker panels)... Full report
    The evidence behind this score 7 cited points
    • At least 8-10 dedicated longevity clinics in Medellín and Bogotá, with physicians holding ISSCA certifications and 15-33 years of experience in regenerative medicine
    • Comprehensive treatment availability including mesenchymal stem cells, exosomes, NAD+ IV therapy, growth hormone secretagogue peptides (Sermorelin, CJC-1295, Tesamorelin), HBOT, biomarker panels, and genetic analysis
    • No published peer-reviewed clinical outcomes data identified; patient satisfaction reports are self-reported marketing surveys, not independently validated
    • Regulatory grey zone: INVIMA has not formally authorized expanded mesenchymal stem cell therapies; proposed 2024 Advanced Therapies Law remains unenacted as of mid-2026
    • Epigenetic clock testing (Horvath, GrimAge) not routinely offered by named clinics; senolytic protocols not advertised
    • Excellent medical tourism infrastructure: 23,323 international patients to Medellín in 2024, mature ecosystem with airport transfers, accommodation, telemedicine follow-up
    • Stem cell anti-aging packages $3,500-$15,000; NAD+ sessions $150-$300; all priced 40-70% below equivalent US/European treatments

    Read the full Colombia report →

  14. 14 Hungary HU 3.5/5 Moderate Hungary has emerging longevity medicine infrastructure with CMC Déli Klinika offering substantive 12-month protocols monitoring 180+ biomarkers and personalized interventions, alongside qualified specialists and stron... Full report
    The evidence behind this score 6 cited points
    • CMC Déli Klinika's comprehensive 12-month longevity program monitors 180+ biomarkers across 23 organ functions with personalized daily health plans and AI-assisted risk modeling
    • Only telomere-based biological age testing widely available (~$192 at DNA-Plusz); no epigenetic clock testing offered in-country
    • No dedicated NAD+ IV therapy clinics, senolytic treatments, or peptide longevity therapies available as formal clinical offerings
    • Published clinical outcomes from Hungarian longevity programs essentially absent in peer-reviewed literature; no registry data or transparent biological age improvement statistics
    • 4-5 Budapest clinics offer longevity-branded services but many blend aesthetics with longevity; medical tourism platforms primarily direct longevity queries toward dental/cosmetic facilities
    • Strong regulatory framework via NNGYK and EU/EMA standards; qualified practitioners including Dr. Balázs Anna (molecular oncology, 25+ years) lead emerging programs

    Read the full Hungary report →

  15. 15 India IN 3.5/5 Moderate India has established multiple longevity clinics with qualified, internationally-trained practitioners and offers comprehensive diagnostic capabilities including epigenetic testing, telomere analysis, and advanced bio... Full report
    The evidence behind this score 7 cited points
    • Multiple dedicated clinics including Biopeak (full-stack longevity clinic), C4 Lifestyle Diagnostics, The Anti-Aging Centre with locations in Gurugram, Delhi, and Pune, and JIVITA at Reliance Foundation Hospital
    • Advanced diagnostic capabilities: Biopeak offers 130+ biomarker blood panels, epigenetic profiling via Aiwo's TruDiagnostics, telomere testing, genetic analysis, and comprehensive health assessments
    • Available treatments including NAD+ IV therapy, stem cell therapy for anti-aging (approximately $9,300), emerging peptide therapies (though many peptides like BPC-157 and Thymosin Alpha-1 lack formal DCGI approval)
    • Personalized 12-month programs at TAC with multidisciplinary teams and follow-up biomarker testing at 9-month intervals
    • Strong medical tourism infrastructure with visa assistance, language support, and treatment costs one-tenth of comparable US/UK pricing
    • Critical gap: published clinical outcomes data for Indian longevity programs remains limited; research institutions focus primarily on individual diseases rather than aging processes
    • Regulatory concerns: many peptide therapies fall into experimental/off-label treatment category with undefined legal status; quality variability concerns due to rapid clinic expansion

    Read the full India report →

  16. 16 South Korea KR 3.5/5 Moderate South Korea demonstrates strong regenerative medicine capabilities and world-class medical tourism infrastructure with excellent cost-effectiveness, but lacks the comprehensive dedicated longevity medicine facilities ... Full report
    The evidence behind this score 7 cited points
    • Limited dedicated longevity medicine facilities: primarily CHAUM Life Center and VEI Clinic, far fewer than Switzerland or U.S. specialized centers
    • Strong regenerative medicine infrastructure: Advanced Regenerative Medicine Act certified 93 institutions and approved 38 clinical applications by 2024, with stem cell therapy $1,300-$2,000 (91% less than U.S.)
    • Limited commercial biological age testing: impressive research (KoMethylNet achieving 2.82-year accuracy) but minimal consumer access to epigenetic clocks and telomere testing
    • Minimal senolytic treatment availability: senolytic compounds remain in early clinical trials globally with no clear evidence of commercial clinical availability in South Korea for longevity purposes
    • Outstanding medical tourism infrastructure: 1.17 million foreign patients in 2024 from 202 countries, packages $4,000-$10,500 with 40-70% savings, JCI-accredited facilities with multilingual staff
    • Limited comprehensive longevity protocols: most facilities focus on individual treatments (stem cells, NAD+, exosomes) rather than integrated multi-modal longevity programs combining genetic testing, biomarker optimization, and personalized interventions
    • Scarce outcomes data: published clinical outcomes for comprehensive longevity programs remain limited, with most evidence focused on aesthetic outcomes or disease treatment rather than biomarker-measured biological age reversal

    Read the full South Korea report →

  17. 17 Poland PL 3.5/5 Moderate Poland operates 4-5 serious dedicated longevity clinics with qualified physician-leaders holding PhD/MD credentials, offering comprehensive treatments (NAD+ therapy, stem cell therapies, exosome treatments, peptide pr... Full report
    The evidence behind this score 6 cited points
    • At least 4-5 serious dedicated clinics identified (Longevity Center Poland, NOVACELL, Klinika Długowieczności, NAMI, VIMED) with multidisciplinary physician teams holding PhD and MD/PhD credentials
    • Comprehensive treatment availability: NAD+ optimization, autologous/allogeneic stem cell therapy, exosome treatments, peptide protocols, HBOT, cryotherapy confirmed at multiple facilities
    • Advanced diagnostics available: epigenetic age assessment, telomere length analysis, Whole Exome Sequencing, biological age testing, genetic biomarker panels at leading clinics
    • Documented regulatory failure: peer-reviewed literature (PMC 2023) identifies exploitation of EU hospital exemption rules with 1,800+ unproven Wharton's jelly cell injections 2011-2022 and documented adverse events including permanent vision loss
    • Medical tourism infrastructure: 700,000 medical tourists visited Poland in 2024; English language support standard at Warsaw clinics; costs 50-70% below UK/Scandinavia/US pricing
    • Evidence gap: No peer-reviewed clinical outcome data published from Poland's longevity program protocols; no Joint Commission International accreditation for specialist longevity clinics

    Read the full Poland report →

  18. 18 Turkey TR 2.5/5 Moderate Turkey offers basic longevity medicine infrastructure with 10+ clinics providing NAD+ therapy, stem cell treatments, and some JCI-accredited facilities with good medical tourism support. However, critical gaps prevent... Full report
    The evidence behind this score 6 cited points
    • Over 10 longevity health clinics in Turkey, primarily concentrated in Istanbul, though most emphasize aesthetic medicine over comprehensive longevity protocols
    • Zero peer-reviewed publications documenting biological age improvements or clinical outcomes from Turkish longevity medicine programs
    • NAD+ IV therapy (€545/session) and stem cell therapy ($5,000-$12,000) available, but no senolytic treatments (dasatinib+quercetin, fisetin) identified despite being established interventions
    • Biological age testing mentioned but no validated epigenetic clocks (Horvath, GrimAge, PhenoAge, DunedinPACE) identified; validation methodology unclear
    • Strong medical tourism infrastructure with JCI-accredited facilities, GMP-certified stem cell production at Liv Hospital, and experienced practitioners (Dr. Tuncay Taş with 20+ years), but no board certification in longevity medicine from recognized international bodies
    • Permissive regulatory environment allows experimental treatments unavailable in many EU countries, raising concerns about evidence standards and enabling marketing of unproven interventions

    Read the full Turkey report →

  19. 19 Jordan JO 2.0/5 Poor Jordan has very limited dedicated longevity medicine infrastructure, with no specialized clinics focused on clinical longevity interventions. While integrative practices like RAF Clinic and Abdali Hospital's Preventio... Full report
    The evidence behind this score 5 cited points
    • No dedicated longevity medicine clinics identified in Jordan; the 10+ anti-aging clinics listed on medical tourism platforms are predominantly dermatology and aesthetic practices focused on cosmetic rather than clinical longevity interventions
    • Advanced longevity diagnostics including epigenetic age clocks, telomere length testing, and senescent cell burden assessments are not documented as clinically available from any Jordanian provider
    • NAD+ IV therapy, peptide therapies (BPC-157, GHK-CU, epitalon), senolytics, and rapamycin longevity protocols are not documented as clinically available, representing significant gaps compared to developed longevity medicine destinations
    • Anti-aging practitioners identified are primarily board-certified dermatologists and internal medicine physicians with no documented American Board of Anti-Aging/Regenerative Medicine (ABAARM) or equivalent longevity medicine board certification
    • No peer-reviewed studies, institutional clinical outcome reports, or dedicated longevity medicine research programs from Jordan have been identified; no Jordanian institution appears as a partner in international longevity clinical trial registries

    Read the full Jordan report →

Reading the field

What separates a good programme from a dangerous one

Every country above is graded against this published scale — the same 1–5 rubric for longevity medicine quality, top to bottom. How we score →

  1. 5/5 Excellent

    Multiple world-class longevity medicine facilities with board-certified specialists; comprehensive range of evidence-based treatments including NAD+ therapy, cellular therapies, senolytic treatments, and advanced diagnostics; biological age testing with epigenetic clocks readily available; personalized protocols based on genetic and biomarker analysis; published clinical outcomes and research; excellent medical tourism infrastructure with international patient services; costs competitive with international standards; strong safety protocols and regulatory oversight.

  2. 4/5 Good

    Several established longevity medicine clinics with qualified practitioners; good selection of proven treatments including some advanced therapies; biological age testing and comprehensive biomarker analysis available; some personalized treatment approaches; evidence of positive outcomes; reasonable medical tourism accessibility; moderate to high costs but good value; adequate safety and regulatory compliance.

  3. 3/5 Moderate

    Some longevity medicine services available but limited facilities; basic anti-aging treatments with few advanced interventions; limited biological age testing options; primarily standardized rather than personalized protocols; minimal published outcomes data; basic medical tourism services; costs vary widely; standard safety protocols; some regulatory oversight.

  4. 2/5 Poor

    Very limited longevity medicine options; few qualified specialists; basic anti-aging services only; limited diagnostic capabilities; no personalized approaches; little evidence of effectiveness; poor medical tourism infrastructure; unclear pricing and value; minimal safety protocols; weak regulatory oversight.

  5. 1/5 Very Poor / Unavailable

    No dedicated longevity medicine facilities; no specialized practitioners; no evidence-based longevity treatments available; no biological age testing; no medical tourism infrastructure for longevity services; no regulatory framework for longevity medicine.

The reports

The full country reports under this lens

Each destination we have assessed has a full, cited report — the detailed analysis behind its score. The verdict is free; the report is the depth.

Clinics & providers

The clinics our research names

Named hospitals, clinics and centres cited across these findings — each carrying the specialties our reports record. Follow one to the reports behind it.

References

The sources behind these assessments

The distinct sources cited across these published reports — every finding carries its own citations; this is the union, each linking back to the reports that lean on it.

  1. Untitled source agingpharma.org/longevitymedtrackprogram2024 Cited in Longevity Medicine Quality in United States
  2. Untitled source agurgentcare.com/telomere-testing-your-health-how-dna-analysis-predicts-biological-age Cited in Longevity Medicine Quality in Turkey
  3. Untitled source aiwo.com/products/epigenetic-test Cited in Longevity Medicine Quality in India
  4. Untitled source bangkokstemcells.com/anti-aging-stem-cell-therapy Cited in Longevity Medicine Quality in Thailand
  5. Untitled source beverlyhillsconciergedoctor.com/anti-aging-wellness/peptide-therapy Cited in Longevity Medicine Quality in United States
  6. Untitled source blog.a4m.com/democratizing-longevity-clinic-franchises-investors-and-pioneering-providers-disrupt-the-industry Cited in Longevity Medicine Quality in United States
  7. Untitled source bostonhealthcm.com/nad-plus-therapy-chiang-mai Cited in Longevity Medicine Quality in Thailand
  8. Untitled source bostonhealthlongevity.com Cited in Longevity Medicine Quality in Thailand
  9. Untitled source bostonhealthlongevity.com/longevity-library/epigenetic-age-testing Cited in Longevity Medicine Quality in Thailand
  10. Untitled source c4lifestylediagnostic.com/about-new Cited in Longevity Medicine Quality in India
  11. Untitled source cenegenics.com/cleveland Cited in Longevity Medicine Quality in United States
  12. Untitled source cenegenics.com/peptides-the-next-frontier-in-precision-longevity-medicine Cited in Longevity Medicine Quality in United States
  13. Untitled source cevrehastanesi.com.tr/en/anti-aging-treatment-in-turkey Cited in Longevity Medicine Quality in Turkey
  14. Untitled source cevrehastanesi.com.tr/en/medical-departments/stem-cell-therapy-in-istanbul-turkey Cited in Longevity Medicine Quality in Turkey
  15. Untitled source ckmstemcells.com Cited in Longevity Medicine Quality in Mexico
  16. Untitled source cm.asiae.co.kr/en/article/2025122808431629790 Cited in Longevity Medicine Quality in South Korea
  17. Untitled source cms-lawnow.com/en/ealerts/2023/07/hungary-s-pharma-authority-to-merge-with-the-national-public-health-centre Cited in Longevity Medicine Quality in Hungary
  18. Untitled source cmtm-mexico.com/en Cited in Longevity Medicine Quality in Mexico
  19. Untitled source communities.springernature.com/posts/senolytics-and-the-longevity-of-healthy-humans Cited in Longevity Medicine Quality in Turkey
  20. Untitled source coraeon.com/local/functional-medicine-wellness-longevity-specialist-ankara-turkey-tr Cited in Longevity Medicine Quality in Turkey
  21. Untitled source coremedical.mx/medical-specialties/regenerative-medicine Cited in Longevity Medicine Quality in Mexico
  22. Untitled source cosmosclinic.com.tr/anti-aging-program Cited in Longevity Medicine Quality in Turkey
  23. Untitled source dioraphuket.com/treatments/intravenous-injections Cited in Longevity Medicine Quality in Thailand
  24. Untitled source dnalabsindia.com/test/genealogy-telmore-age-testing Cited in Longevity Medicine Quality in India

Explore the source archive →

In plain language

Start exploring the knowledge base

The field's shorthand our reports use, sized by how often it comes up. Follow any term to its full entry and the reports that use it.

For readers weighing this decision

Ways to read the evidence

The verdict is always free. A membership opens the full analysis and every cited source — this specialty, the whole library, or everything for good.

  • One specialty · annual

    Wellness & Preventive Care

    $49.00 / year

    $49.00/year

    Every report in this specialty — full analysis and every cited source — as each is published.

    Take this specialty

  • Full library · annual

    The whole library

    $199.00 / year

    $199.00/year

    The complete evidence behind every finding in every specialty, while your decision is live.

    Take the full library
  • Most readers

    Lifetime · one payment

    Everything, for good

    $499.00 once

    $499.00 (one-time)

    Every finding we publish today and hereafter — no renewal, no expiry. The tier we point most readers to.

    Take lifetime access

Prefer to pay per report? A single report is $29.00, yours to keep — browse the reports. The verdict is always free.

Where to go from here · Longevity Medicine Quality

no scope is a dead end — step up to the specialty, drill into a factor, or pivot across to a country or a comparison